Tom Barnes

Tom Barnes

Company: Orna Therapeutics

Job title: CEO

Seminars:

Panel Discussion 5:00 pm

Read more

day: Day Two

The Therapeutic Potential of oRNA 5:45 pm

Read more

day: Day One

Panel Discussion 5:00 pm

With an increase in investment and development of mRNA technology platforms and upcoming biotechs this calls for further clarity to standardise frameworks for future innovations. It is critical within the mRNA space to streamline practices for mRNA- based therapeutics across the development value chain and overcome key bottlenecks for better clinical translation. How to accelerate…Read more

day: Day Two

The Therapeutic Potential of oRNA 5:45 pm

Engineered circular RNA (oRNA) has significant advantages over mRNA Ease of production allows “omics” approach to expression optimization IV delivery to non-hepatic tissues opens new therapeutic areasRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.